companydata.dkACESION PHARMA ApS: Financial statements 2019
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -35,793,780 and a net result of DKK -41,223,161 compared with DKK -25,088,392 the year before. Equity amounted to DKK 523,693. The solvency ratio was 1.7%. The company had 7 employees in the financial year.
- Gross Profit
- -35,793,780 kr.
- Profit/Loss
- -41,223,161 kr.
- Equity
- 523,693 kr.
- Total Assets
- 31,475,328 kr.
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -35.8 mio. | -41.2 mio. | 524 t. | 7 |
| 2018 | - | -18.6 mio. | -25.1 mio. | -6.5 mio. | 10 |
| 2017 | - | -17.5 mio. | -24 mio. | -9.9 mio. | 12 |
| 2016 | - | -14.4 mio. | -18.3 mio. | 14.1 mio. | - |
| 2015 | - | -8.5 mio. | -9.8 mio. | 1.5 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
As of September 9, 2019, Morten Døssing has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Karen Juo-Lai Chu has joined the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Stephan Christgau has left the board of directors of ACESION PHARMA ApS.
As of September 9, 2019, Duan Xiang has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -18,647,333, and the net result was DKK -25,088,392.
As of January 23, 2019, Duan Xiang has joined the board of directors of ACESION PHARMA ApS.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.